RON MAYRON

RON MAYRON

Executive Chairman

Mr. Ron Mayron has extensive experience in the pharmaceutical & medical device arena. His core expertise is in Marketing, Sales & Distribution, Mergers & Acquisitions, Business Development, Global Operations & Supply Chain and Strategic Development.

Ron served as CEO of Teva Israel and VP – Israel and Africa between 2009 and 2013 where he was responsible for entering the infant formula market in a partnership with Groupe Danone SA (Euronext: BN) unit Nutricia.

From 2007 to 2008 he managed the Commercial Affairs of the Teva International Group, which included operations in more than 30 countries.

From 2008 to 2009 he established and managed the new Russia & Regional Markets for Teva, including Russia & CIS countries (ex-USSR), Croatia & ex-Yugoslavia and Middle East & North Africa countries.

Ron was responsible for developing the Teva Israel growth strategy and entering new business activities in healthcare. As a result of his leadership, the company realized an increase in income of more than $650 million in 2013.

IRIS BINCOVICH

IRIS BINCOVICH

CEO

Mrs. Iris Bincovich is an experienced healthcare manager, with a proven track record in developing global business strategies to open and penetrate new markets. With nearly 20 years of international marketing, biz dev and sales experience, she has led and managed hundreds of successful international transactions in the OTC, cosmetics and dermatology sector.

Iris was formerly the VP Global Marketing & Sales for the OTC botanical specialist, Kamedis, where she established their successful International marketing strategy including establishing digital marketing platform and global e-commerce site. She has also led the marketing/sales strategy and world-wide distribution network for a variety of dermatology, cosmetic and OTC companies (Promedico (Wellcome), Pollogen (Lumenis; NASDAQ: LMNS), Starlet Derma, Power Paper) and has worked with leading international cosmetic customers (Estee Lauder, L’Oreal, J&J, Channel, etc.).

Whilst serving as the Business Unit Manager for Tagra, she accompanied the biotechnology startup from early stage to commercialization and established their worldwide distribution network.  

​​

RONI KAMHI

RONI KAMHI

COO & CEO BI Sky Global

Over 20 years of experience in global eCommerce and technology with a focus on Digital, Analytics and Data. Roni has scaled eCommerce startups from an early stage to 9 figures in revenue.

NELSON HALPERN

NELSON HALPERN

FCPA, FCA, TEP CFO

Extensive experience as CFO for public and private companies. Member of the Chartered Professional Accountants of Alberta. Received a Distinguished Service Award from the Chartered Professional Accountants of Alberta in 2005 and received an “FCA” designation as a Fellow Chartered accountant in 2013 for his contribution to his community and the profession.

EYAL KALO

EYAL KALO

R&D Director

Dr.Eyal Kalo earned his Ph.D from the Weizmann Institute of Science mastering in the field of cancer research. Eyal completed his studies in 2010 and joined the biotechnology industry where he gained expertisse in leading various R&D projects from concept to launch in the field of medical diagnostics, and natural medicine. Eyal worked as a scientific team leader at the molecular diagnostic division of Beckman Coulter and was responsible for the development of an FDA approved molecular-based diagnostic assay to detect HIV in patients. Prior to that, he served as a senior project manager at IBR Ltd. A company that is under IFF’s structure and develops, manufactures and markets innovative and proprietary natural active ingredients.